A Community Based Program to Increase Breast and Cervical Cancer Screening and HPV Vaccination to Reduce the Impact of Breast and Cervical Cancer Among Latinas.
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 8,000
- 试验地点
- 2
- 主要终点
- Number of women 18-26 years who initiate (complete first dose) of the HPV vaccine
研究概览
简要总结
The purpose of this study is to increase early detection and prevention of breast and cervical cancer through education and navigation and to increase breast and cervical cancer screening and Human Papillomavirus (HPV) vaccination in underserved Latinas.
详细描述
This is an evaluation of the implementation of the Salud en Mis Manos program. The investigators evaluate the effect of the program on increasing participant breast and cervical cancer screening and HPV vaccination using a one-group pre-post study design (2022-2024). The investigators also describe the implementation of the program during a longer time period (2020-.2024).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 74 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Primarily residing in the Gulf Coast & Lower Rio Grande Valley county areas (or other counties in Texas)
- •Women 40 years of age and older with no mammogram in the past 2 years
- •Women 21-65 years, with no Pap test in the past 3 years
- •Women aged 18-26 years, who have not initiated or completed the HPV vaccine series, and through age 45 years if Advisory Committee on Immunization Practices (ACIP) recommends the FDA-approved age expansion for HPV vaccination for older individuals.
排除标准
- •Current pregnancy
- •Have a current or prior cancer diagnosis
结局指标
主要结局
Number of women 18-26 years who initiate (complete first dose) of the HPV vaccine
时间窗: Between baseline and end of study (about 9 months)
Among women 18-26 years that have not had any HPV vaccination at baseline, enrolled in the program and self-report first HPV vaccine completed on follow-up surveys.
Number of women 40 and older who complete mammogram screening
时间窗: Between baseline and end of study (about 9 months)
Among women 40 and older enrolled in the program who have not had a mammogram in the past 2 years at baseline and who self-report mammogram screening completed on follow-up surveys
Number of women 21-65 years who complete Pap test screening
时间窗: Between baseline and end of study (about 9 months)
Among women 21-65 years enrolled in the program who have not had a Pap test screening in the past three years at baseline, and who self-report Pap or HPV screening on follow-up surveys.
次要结局
- Number of women 18-26 years who receive dose 3 of HPV vaccine(between baseline and end of study (about 9 months))
- Number of women 18-26 years who receive dose 2 of HPV vaccine(between baseline and end of study (about 9 months))
研究者
Lara Savas
Associate Professor
The University of Texas Health Science Center, Houston